The size of the Pharmaceutical Gelatin Market in Europe is forecasted to grow at a robust CAGR from 2021 to 2026.
Gelatin is the main ingredient for a lot of drug coating manufacturing processes. Hence the pharmaceutical gelatin market is witnessing abundant growth due to its wide range of applications. The gelatin used in pharmaceuticals is water-soluble, transparent, colorless, and delicate.
The benefits associated with the pharmaceutical gelatin is majorly accelerating the market growth in the Europe region. It is used in various forms, such as making empty capsules, tablet coating, suspending agents, and a plasma substitute. Factors such as the rising prevalence of chronic diseases, an increase in population and spread rate of infections, governments support, and private organizations' support are driving market size for the European pharmaceutical gelatin market. Also, Europe is the first nation to account for a more significant number of geriatric populations. The rise in awareness for neutraceuticals, and the intake of natural drugs, and the increase in the geriatric population increase market growth.
Along with market growth factors, few restraints held back market growth for the European region's pharmaceutical gelatin market. The high-end costs are associated with gelatin as the extraction procedures are more challenging. Hence this high cost of gelatin hampers the market growth. The preservation and conditions for gelatin are to do with more skilled persons in favorable environments. Therefore such factors interfere with the market size. The availability and production of gelatin in European nations are also not that great compared to other countries.
This market research report on the Europe Pharmaceutical Gelatin Market has been segmented and sub-segmented into the following categories:
By Function:
By Source:
By Application:
By Country:
Geographically, The Pharmaceutical Gelatin market was dominated by Europe closely followed by North America. Asia Pacific is expected to grow at a high CAGR.
Out of Europe, Germany holds the largest shares, followed by Italy and France. Rise in geriatric population ratio, awareness in neutraceuticals, rise in occurrences of chronic diseases. Also, the wide range of gelatin applications in various markets, such as pharmaceuticals and nutraceuticals, is causing market growth to a great extent. Europe is the first country to report more research-based activities for plant-based drugs, i.e., neutraceuticals. This country also has a vast scope of pharmaceuticals and drug manufacturing companies that need a lot of gelatin to manufacture capsules and tablets. It acts as a suspending agent who made it more beneficial.
Some of the major companies dominating the Europe pharmaceutical gelatin market by their products and services include Rousselot, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Tessenderlo Group, Sterling Gelatin, Roxlor LLC, Weishardt, and Gelita AG.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Function
5.1.1 Introduction
5.1.2 Stabilizers
5.1.3 Thickeners
5.1.4 Gelling agents
5.1.5 Y-o-Y Growth Analysis, By function
5.1.6 Market Attractiveness Analysis, By function
5.1.7 Market Share Analysis, By function
5.2 Source
5.2.1 Introduction
5.2.2 Pig skin
5.2.3 Bovine hides
5.2.4 Bones
5.2.5 Y-o-Y Growth Analysis, By source
5.2.6 Market Attractiveness Analysis, By source
5.2.7 Market Share Analysis, By source
5.3 Application
5.3.1 Introduction
5.3.2 Hard capsules
5.3.3 Soft capsules
5.3.4 Micro encapsulation
5.3.5 Coating
5.3.6 Absorbable hemostat
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By function
6.1.3.3 By source
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By function
6.1.4.3 By source
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By function
6.1.5.3 By source
6.1.5.4 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Rousselot
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Tessenderlo Group
8.3 Nitta Gelatin Inc.
8.4 Capsugel
8.5 Catelent Inc.
8.6 Norland Products Inc
8.7 Sterling Gelatin
8.8 Weishardt
8.9 Gelita AG
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
